RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $1.0M of Relay Therapeutics, Inc.
Sold$1,018,080
$24.24Price
42,000Shares
−3%Stake
What RLAY did after the filing
- The stock from Fri, Sep 16 open, $24.93
- −9.7%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Oct 28 close.
Traded Tue, Sep 13. Filed Thu, Sep 15, 5:02 PM ET, after the close. Returns use the Sep 16 open and the Oct 28 close. Not investment advice.